fda import alert 66-80 glp-1 api green list creates "green list" to block unsafe imports | FDA posted on the topic FDA Launches “Green List” to

The FDAs current guidance, updated June 15, 2026, is blunt about what the category means: compounded GLP-1s skip the agencys review for safety, effectiveness, and quality entirely, and as of May 31, 2026 the FDA had logged 990 adverse-event reports for compounded semaglutide and more than 730 for compounded tirzepatide, per the FDAs compounded GLP-1 page

Compounded options from licensed 503A pharmacies offer customization and may cost less, with quality resting on the individual pharmacy

One of these fake samples contained no API, whereas sildenafil contamination was identified in another

This is when having a meal-building framework (like the one we teach in The Blood Sugar Method) becomes essentialyoull know exactly what to eat to meet your nutritional needs even with reduced hunger

These stories highlight the profound impact that GLP-1 therapies can have on the lives of individuals with PCOS

our formula is free of common irritants like parabens, sulfates, silicones, or artificial fragrances